Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.
3.

Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.

Rousse S, Lallemand F, Montarras D, Pinset C, Mazars A, Prunier C, Atfi A, Dubois C.

J Biol Chem. 2001 Dec 14;276(50):46961-7. Epub 2001 Oct 11.

8.

Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells.

Simeone DM, Zhang L, Graziano K, Nicke B, Pham T, Schaefer C, Logsdon CD.

Am J Physiol Cell Physiol. 2001 Jul;281(1):C311-9.

9.

C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.

Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M.

Am J Respir Cell Mol Biol. 2003 Jun;28(6):754-61.

PMID:
12760970
10.

Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.

Ungefroren H, Lenschow W, Chen WB, Faendrich F, Kalthoff H.

J Biol Chem. 2003 Mar 28;278(13):11041-9. Epub 2003 Jan 20.

11.

p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.

Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F.

Exp Cell Res. 1999 Aug 1;250(2):351-63.

PMID:
10413589
12.

The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.

Atfi A, Prunier C, Mazars A, Défachelles AS, Cayre Y, Gespach C, Bourgeade MF.

Oncogene. 1999 Jul 1;18(26):3878-85.

13.

Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.

Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E.

J Biol Chem. 1999 Sep 17;274(38):27161-7.

15.
16.

c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity.

Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM, Atfi A.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):6198-203.

17.

Regulation of fibronectin by thyroid hormone receptors.

Lin KH, Chen CY, Chen SL, Yen CC, Huang YH, Shih CH, Shen JJ, Yang RC, Wang CS.

J Mol Endocrinol. 2004 Oct;33(2):445-58.

PMID:
15525600
18.

Role of Ras and Mapks in TGFbeta signaling.

Mulder KM.

Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):23-35. Review.

PMID:
10708950
19.

ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling.

Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S.

J Biol Chem. 1999 Mar 26;274(13):8949-57.

Supplemental Content

Support Center